Ayson, Klent .

HRN: 28-80-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/09/2026
04/15/2026
IV
2.5g
Q8H
T/C Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: